Article

Advice for Pharmacists in Preparing for USP 800 Regulations

In this clip, Jennifer Bruckart, CPhT, Director of Operations and Compliance at WeCare Pharmacy, discusses how community pharmacists can prepare for the new USP 800 regulations.

In this clip, Jennifer Bruckart, CPhT, Director of Operations and Compliance at WeCare Pharmacy, discusses how community pharmacists can prepare for the new USP 800 regulations.

Related Videos
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Senior Doctor is examining An Asian patient.
Healthcare, pharmacist and woman at counter with medicine or prescription drugs sales at drug store.
Image Credit: © Birdland - stock.adobe.com
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
Hurricane Helene, Baxter plant, IV fluids shortage, health systems impact, injectable medicines, compounding solutions, patient care errors, clinical resources, operational consideration, fluid conservation, sterile water, temperature excursions, training considerations, patient safety, feedback request
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
Related Content
Before the Big Event: AI-Enabled Remote Cardiac Monitoring Can Mitigate Stress-Related Cardiovascular Events
December 2nd 2024

Before the Big Event: AI-Enabled Remote Cardiac Monitoring Can Mitigate Stress-Related Cardiovascular Events

Stuart Long
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
PREP Act, COVID-19, Pandemic, Pharmacy, Immunization | Image Credit: ©dusanpetkovic1 | stock.adobe.com
December 2nd 2024

Looming PREP Act Expiration Could Impact Health Care Access for Rural Patients

Ashley Gallagher, Associate Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

FDA Approval, Ustekinumab, Stelera, Crohn disease, Plaque Psoriasis, Psoriatic Arthritis | Image Credit: © Araki Illustrations | stock.adobe.com
Published: December 2nd 2024 | Updated: December 2nd 2024

FDA Approves Ustekinumab-kfce as Sixth Biosimilar to Stelara

Ashley Gallagher, Associate Editor
Familiarize Yourself With Updated Clinical Guidelines Recommendations for Restless Legs Syndrome
December 1st 2024

Familiarize Yourself With Updated Clinical Guidelines Recommendations for Restless Legs Syndrome

Kamila Dymala, PharmD, RPh, MBA, BCMTM, PACS